Hutch News

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
News Releases - February 05, 2021
Fred Hutch, UW Medicine alliance with Takeda to advance promising early-stage research

Fred Hutch, UW Medicine alliance with Takeda to advance promising early-stage research

Collaboration aims to accelerate next generation treatments in cancer, gastrointestinal diseases, and neurological disorders
News Releases - February 21, 2018